MedPath

Evolution of Pulmonary Capillary Blood Volume

Completed
Conditions
Pulmonary Embolism
Interventions
Other: diffusion NO/CO method
Registration Number
NCT00941187
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

The purpose of this monocentric, preliminary study is to assess the evolution of pulmonary capillary blood volume (Vc), measured by the double diffusion nitric oxide/carbon monoxide (NO/CO) method (Guenard et al.; Respir Physiol 1987), from the starting of the anticoagulant therapy to 6 months after, and to search correlations with the evolution of clinical (dyspnea and results of the 6 minutes walking test), biological (BNP; Troponin), echocardiographic (right ventricular dysfunction, pulmonary arterial pressure) and ventilation/perfusion lung scan data.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Patient with a first episode of symptomatic pulmonary embolism, treated with anticoagulant
  • Age from 18 to 75 years-old
Exclusion Criteria
  • Confirmed pulmonary embolism in the past
  • Massive pulmonary embolism, thrombolytic treatment
  • Confirmed left heart systolic dysfunction
  • Confirmed asthma, chronic obstructive pulmonary disease or pulmonary fibrosis
  • Expected life below 6 months
  • Pleural effusion with indication of evacuation
  • Bronchopulmonary cancer
  • Pulmonary surgery with resection of two lobes minimum
  • Predictable incapacity to complete the 6 minutes walking test

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
patients after a first episode of pulmonary embolismdiffusion NO/CO method-
Primary Outcome Measures
NameTimeMethod
difference of pulmonary capillary blood volume (Vc) from J0 to 6 monthsfrom the starting of the anticoagulant therapy to 6 months after
Secondary Outcome Measures
NameTimeMethod
correlations with the evolution of clinical (dyspnea and results of the 6 minutes walking test), biological (BNP; Troponin), echocardiographic (right ventricular dysfunction, pulmonary arterial pressure) and ventilation/perfusion lung scan datafrom the starting of the anticoagulant therapy to 6 months after

Trial Locations

Locations (2)

Departement of pneumology, CHU Saint-Etienne

🇫🇷

Saint-Etienne, France

Department of Medicine and Therapeutic, CHU Saint-Etienne

🇫🇷

Saint-etienne, France

© Copyright 2025. All Rights Reserved by MedPath